ALLR Latest Press Releases

-- December 31, 2025 --

Allarity Therapeutics Issues 2025 End of Year CEO Letter to Shareholders Globe Newswire 8:00 AM

-- November 14, 2025 --

Allarity Therapeutics Provides Third Quarter 2025 Financial Results and Provides Business Updates Globe Newswire 9:00 AM

-- September 22, 2025 --

Allarity Therapeutics Presents New Phase 2 Clinical Data for Stenoparib/2X-121 Showing Landmark Median Overall Survival Has Now Surpassed 25 Months Globe Newswire 8:00 AM

-- September 17, 2025 --

Allarity Therapeutics CEO to Present at Biomarkers & Precision Medicine 2025 Globe Newswire 8:00 AM

-- August 26, 2025 --

Allarity Therapeutics Granted FDA Fast Track Designation for Stenoparib for the Treatment of Advanced Ovarian Cancer Globe Newswire 8:00 AM

-- August 15, 2025 --

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships Globe Newswire 4:30 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software